Rosie Mngqibisa
4PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 29, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study.Nila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto
|Aug 13, 2025
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans.Rosie Mngqibisa, Yashna Singh, Catherine Orrell
|Aug 30, 2022
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.Anchalee Avihingsanon, Michael D Hughes, Robert Salata
|Mar 05, 2021
Accelerating drug discovery for pregnant and lactating women living with HIV.Risa M Hoffman, Rosie Mngqibisa, Dawn Averitt
Pageof 1
Frequent Collaborators
1 joint publications
Risa M Hoffman
1 joint publications
Anchalee Avihingsanon
1 joint publications
Catherine Godfrey
1 joint publications
Marije Van Schalkwyk
1 joint publications
Maganizo Chagomerana
1 joint publications
Yashna Singh
1 joint publications
Catherine Orrell
1 joint publications
Johan Lombaard
1 joint publications
Sandy Griffith
1 joint publications
Conn Harrington
